Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Common Stock Issued (2025 - 2026)

Updated

Adaptin Bio (APTN) reported Common Stock Issued of $929,106 for Q2 2026, up 42.5% from the prior quarter.

Analysis

Adaptin Bio (APTN) Common Stock Issued (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Adaptin Bio's Common Stock Issued came in at $2.58 million; for FY2025, it was $7.16 million.

  • Common Stock Issued has a three-year compound annual growth rate of 2328.5% (FY2022 to FY2025).
  • By year, Common Stock Issued came in at $500.00 in FY2022.
  • Five-year quarterly Common Stock Issued spans a low of $652,000 in Q1 2026 and a high of $6.16 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Adaptin Bio 56.76 Mn 54.75 Mn - 929,106.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 929,106.00
Mar 31, 2026 652,000.00
Dec 31, 2025 999,999.00
Mar 31, 2025 6.16 Mn
API Access

Adaptin Bio Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=APTN&period=max&api_key=YOUR_API_KEY